A cost-effectiveness analysis of the ZIRA test in breast cancer

Carole Siani, Christian de Peretti, Julie A Vendrell, Balazs Gyorffy (), Thomas Bachelot (), Nicolas Plommet, Pascale Cohen and Lionel Perrier
Additional contact information
Julie A Vendrell: UNICANCER/CRCL - Centre de Recherche en Cancérologie de Lyon - Centre Léon Bérard [Lyon] - UCBL - Université Claude Bernard Lyon 1 - Université de Lyon - INSERM - Institut National de la Santé et de la Recherche Médicale - CNRS - Centre National de la Recherche Scientifique
Balazs Gyorffy: Semmelweis University [Budapest]
Thomas Bachelot: Oncogénèse et progression tumorale - Centre Léon Bérard [Lyon] - UCBL - Université Claude Bernard Lyon 1 - Université de Lyon - INSERM - Institut National de la Santé et de la Recherche Médicale, Département de Médecine Nucléaire - Centre Léon Bérard [Lyon]
Nicolas Plommet: Centre Léon Bérard [Lyon]
Pascale Cohen: UNICANCER/CRCL - Centre de Recherche en Cancérologie de Lyon - Centre Léon Bérard [Lyon] - UCBL - Université Claude Bernard Lyon 1 - Université de Lyon - INSERM - Institut National de la Santé et de la Recherche Médicale - CNRS - Centre National de la Recherche Scientifique

Post-Print from HAL

Keywords: Zira test; breast cancer (search for similar items in EconPapers)
Date: 2016-05-21
References: Add references at CitEc
Citations:

Published in 21th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, May 2016, Washington, United States

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:halshs-01366993

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().